Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000378:metabolism; D005730:Ganglionic Blockers; D006339:Heart Rate / Q000187:drug effects; D006977:Hypertension, Renal / Q000188:drug therapy; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D008099:Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011744:Pyrimidinones / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D013329:Structure-Activity Relationship
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D011744:Pyrimidinones; D009638:Norepinephrine; D004837:Epinephrine